Bromide

Bromide

SCHEMBL7301782

Br.O=c1[nH]c(=O)n(CCCCN2CC=C(c3ccccc3)CC2)c2cc(O)ccc12

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HTR1A known ✓ P08908 1/20 0.53
PARP1 P09874 17/20 0.62
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 1/20 0.53
CYP2C9 P11712 1/20 0.53
DRD2 P14416 1/20 0.53
TSHR P16473 1/20 0.53
DRD4 P21917 1/20 0.53
CYP2C19 P33261 1/20 0.53
DRD3 P35462 1/20 0.53
TDP1 Q9NUW8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7309634 0.92 PARP1 (0.62) PARP1CYP1A2CYP3A4HTR1AMAPT
SCHEMBL7307656 0.91 PARP1 (0.63) PARP1CYP1A2CYP3A4HTR1AMAPT
Bromide SCHEMBL7303725 0.89 PARP1 (0.63) PARP1CYP1A2CYP3A4HTR1AMAPT
SCHEMBL7303316 0.88 PARP1 (0.64) PARP1CYP1A2CYP3A4HTR1AMAPT
Hydrochloric Acid SCHEMBL7301544 0.87 PARP1 (0.63) PARP1MAPT
SCHEMBL7308221 0.87 PARP1 (0.63) PARP1
SCHEMBL7305161 0.87 PARP1 (0.73) PARP1
SCHEMBL7308137 0.85 PARP1 (0.60) PARP1HTR1A
Bromide SCHEMBL9430973 0.85 TDP1 (0.55) PARP1CYP1A2CYP3A4HTR1AMAPT
SCHEMBL7306617 0.84 PARP1 (0.59) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US claimed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP claimed
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed